Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of (177)Lu‐PSMA‐617 in prostate cancer patients

Studies to evaluate and optimize [(177)Lu]Lu‐PSMA treatment focus primarily on individual patient data. A population pharmacokinetic (PK) dosimetry model was developed to explore the potential of using imaging data as input for population PK models and to characterize variability in organ and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebinga, Hinke, Privé, Bastiaan M., Peters, Steffie M. B., Nagarajah, James, Dorlo, Thomas P. C., Huitema, Alwin D. R., de Wit‐van der Veen, Berlinda J., Hendrikx, Jeroen J. M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431047/
https://www.ncbi.nlm.nih.gov/pubmed/36760133
http://dx.doi.org/10.1002/psp4.12914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431047/
https://www.ncbi.nlm.nih.gov/pubmed/36760133
http://dx.doi.org/10.1002/psp4.12914

Ejemplares similares